Can fibroadenoma present with a lobulated configuration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Fibroadenoma Be Lobulated?

Yes, fibroadenomas can present with a lobulated configuration—this is a recognized benign feature that occurs in approximately 28% of cases and does not necessarily indicate malignancy.

Imaging Characteristics of Fibroadenomas

Fibroadenomas typically present as solid, round, well-circumscribed masses with or without lobulated features 1. The lobulated appearance is one of several morphologic patterns that fibroadenomas can exhibit on imaging studies.

Ultrasound Features

On ultrasound evaluation, fibroadenomas demonstrate:

  • Round or oval shape (with lobulation present in 28.3% of cases) 2
  • Circumscribed margins (57.8% of cases) 2
  • Hypoechoic appearance (91.3% of cases) 2
  • Homogeneous echogenicity with orientation parallel to the chest wall 3

The presence of lobulation does not exclude the diagnosis of fibroadenoma, as this feature can coexist with other benign characteristics.

MRI Characteristics

On MRI, fibroadenomas show:

  • Round or lobulated shape in 90-100% of cases 4, 5
  • Well-defined margins (70-87% of cases) 5
  • Smooth or lobulated borders are highly predictive of benign disease (97-100% specificity) 4

Clinical Significance

The lobulated configuration alone should not trigger concern for malignancy when other features remain benign. Smooth or lobulated borders on high spatial-resolution MR imaging are highly predictive of benign disease with 97-100% accuracy 4.

When to Be Concerned

While lobulation is acceptable in fibroadenomas, you should pursue biopsy when:

  • Noncircumscribed margins are present (21.7% of fibroadenomas may show this atypical feature) 2
  • Spiculated borders appear (76-88% predictive of malignancy) 4
  • The mass is new or enlarging >20% in volume over 6 months 3
  • Heterogeneous internal structure is prominent 2
  • Posterior acoustic shadowing is present 2

Management Algorithm

For a lobulated mass with otherwise benign features:

  • Age ≥40 years: Diagnostic mammography plus targeted ultrasound 3
  • Age 30-39 years: Ultrasound first, consider mammography if features are not definitively benign 3
  • Age <30 years: Ultrasound alone is typically sufficient 3

If the lobulated mass demonstrates circumscribed margins, homogeneous echogenicity, and parallel orientation on ultrasound, short-interval follow-up (rather than immediate biopsy) is appropriate when clinical examination is concordant 3.

The key pitfall is assuming all lobulated masses require biopsy—lobulation is a normal variant in fibroadenomas when accompanied by other benign features such as circumscribed margins and homogeneous internal structure.

References

Research

Fibroadenoma: a guide for junior clinicians.

British journal of hospital medicine (London, England : 2005), 2022

Research

An Evaluation of Ultrasound Features of Breast Fibroadenoma.

Advanced biomedical research, 2017

Guideline

acr appropriateness criteria<sup>®</sup> palpable breast masses.

Journal of the American College of Radiology, 2017

Research

Differentiation of phyllodes breast tumors from fibroadenomas on MRI.

AJR. American journal of roentgenology, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.